𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗔𝗺𝘆𝗹𝗼𝗶𝗱𝗼𝘀𝗶𝘀 𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗮𝘁 𝗨𝘀𝟮.𝗮𝗶 🚀 Us2.ai is the 𝘰𝘯𝘭𝘺 AI-echo solution enabling fully automated Cardiac Amyloidosis parameter measurements aligned with Guideline Directed Echocardiography Reporting (GDER). Us2.ai achieved FDA clearance for this in June 2024, with additional approvals in Japan and Canada this year. 𝗔𝗻𝗱 𝗻𝗼𝘄 𝘁𝗵𝗲𝗿𝗲 𝗶𝘀 𝗠𝗢𝗥𝗘!💡 Using a single 4-chamber image clip, Us2.ai can now accurately detect amyloidosis on echocardiography. The results have been presented as a late-breaking science at #EuroEcho2024 in Berlin this month. 𝗪𝗮𝗻𝘁 𝘁𝗼 𝘀𝗲𝗲 𝘁𝗵𝗲 𝗱𝗲𝘁𝗮𝗶𝗹𝘀? ➡️ 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝘁𝗵𝗲 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝘃𝗶𝗮 𝘁𝗵𝗲 𝗹𝗶𝗻𝗸 𝗶𝗻 𝘁𝗵𝗲 𝗰𝗼𝗺𝗺𝗲𝗻𝘁𝘀! Our unique comprehensive solution promises to transform early detection and expand access to guideline-recommended treatments for this underrecognized and underdiagnosed disease. 𝙎𝙩𝙖𝙮 𝙩𝙪𝙣𝙚𝙙 𝙛𝙤𝙧 𝙢𝙤𝙧𝙚 𝙖𝙨 𝙬𝙚 𝙬𝙤𝙧𝙠 𝙩𝙤𝙬𝙖𝙧𝙙 𝙁𝘿𝘼 𝙘𝙡𝙚𝙖𝙧𝙖𝙣𝙘𝙚 𝙛𝙤𝙧 𝙩𝙝𝙞𝙨 𝙘𝙖𝙥𝙖𝙗𝙞𝙡𝙞𝙩𝙮 𝙞𝙣 2025!🌟 #AIinHealthcare #Echocardiography #Innovation #Amyloid #AIEcho #Cardiology #CardiacAmyloidosis #PatientsFirst
📄 Access the full presentation here: https://us2.ai/ai-echo-to-diagnose-cardiac-amyloidosis-a-multi-centre-international-development-and-validation-study/